Semler Scientific (NASDAQ:SMLR) Releases Earnings Results, Beats Expectations By $3.21 EPS

Semler Scientific (NASDAQ:SMLR) announced its quarterly earnings results on Tuesday. The company reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21, Zacks reports. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Semler Scientific Stock Up 2.1 %

Shares of SMLR traded up $1.05 on Tuesday, hitting $50.72. The company’s stock had a trading volume of 367,422 shares, compared to its average volume of 426,497. The firm’s fifty day moving average price is $57.63 and its 200-day moving average price is $42.29. Semler Scientific has a fifty-two week low of $20.88 and a fifty-two week high of $81.56. The firm has a market capitalization of $470.17 million, a price-to-earnings ratio of 24.74 and a beta of 1.17.

Wall Street Analyst Weigh In

Separately, Lake Street Capital boosted their price objective on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research report on Friday, January 24th.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.